BeyondSpring Inc. (NASDAQ:BYSI - Get Free Report)'s stock price traded down 4.1% on Monday . The stock traded as low as $2.33 and last traded at $2.35. 22,243 shares were traded during trading, a decline of 31% from the average session volume of 32,420 shares. The stock had previously closed at $2.45.
BeyondSpring Stock Performance
The stock's fifty day simple moving average is $2.08 and its 200-day simple moving average is $1.76.
BeyondSpring (NASDAQ:BYSI - Get Free Report) last released its quarterly earnings results on Monday, May 12th. The company reported ($0.06) earnings per share for the quarter.
About BeyondSpring
(
Get Free Report)
BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia.
See Also
Before you consider BeyondSpring, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BeyondSpring wasn't on the list.
While BeyondSpring currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
